“CTHRC1 is associated with BRAF(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma” (2024) Biomolecules and Biomedicine [Preprint]. doi:10.17305/bb.2024.10397.